APOLLOTYRE.NS Apollo Tyres Limited
Computed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
Healthy business: it turns profit into real cash and earns solid returns on capital.
- Strong cash flow quality
- Positive FCF conversion
- Low accrual ratio indicating credible earnings
Are the smart people buying?
No ownership-change data for this stock. The score reflects heavy growth investment (capex) and buybacks, not visible insider buying.
- Strong capex growth
- Active buybacks
- High promoter/insider ownership
- Significant institutional ownership
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 947.15 vs price 428.65 — screens cheap on a cash-flow DCF (121.0% to intrinsic). The base DCF growth of 15% is not believable given the reverse-DCF implied growth of 4.83%, suggesting the market expects much lower future growth than the model's assumptions.
| Intrinsic / share | 947.15 |
| Price | 428.65 |
| Upside to intrinsic | 121.0% |
| Reverse-DCF implied g | 4.8% |
Base FCF 20.09B · growth 15.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | 11% | 13% | 15% | 17% | 19% |
| 10% | 1022.31 | 1200.51 | 1407.44 | 1647.28 | 1924.72 |
| 11% | 831.64 | 973.56 | 1138.03 | 1328.31 | 1548.06 |
| 12% | 696.18 | 812.55 | ★ 947.15 | 1102.59 | 1281.81 |
| 13% | 595.17 | 692.68 | 805.25 | 935.01 | 1084.38 |
| 14% | 517.09 | 600.18 | 695.91 | 806.07 | 932.66 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 284.71B | 261.23B | 250.20B | 241.22B | — |
| Operating income | 26.00B | 20.73B | 29.91B | 19.15B | — |
| EBITDA | 32.44B | 34.92B | 45.13B | 33.63B | — |
| Net income | 13.72B | 11.21B | 17.22B | 10.46B | — |
| Operating cash flow | 36.67B | 18.23B | 34.40B | 21.37B | — |
| Capex | -14.03B | -7.69B | -7.30B | -7.77B | — |
| Free cash flow | 22.64B | 10.55B | 27.09B | 13.60B | — |
| Total assets | 292.40B | 273.06B | 269.57B | 273.53B | — |
| Total equity | 167.15B | 147.66B | 139.02B | 125.78B | — |
| Total debt | 36.75B | 44.10B | 49.05B | 64.21B | — |
| Cash & equivalents | 10.29B | 8.86B | 9.12B | 8.36B | — |